{"id":2087,"date":"2019-12-05T11:39:41","date_gmt":"2019-12-05T10:39:41","guid":{"rendered":"https:\/\/www.maiwald.eu\/all\/presseberichte\/astrazeneca-appeal-rejected-in-generics-favourable-decision-juve-patent\/"},"modified":"2021-10-01T16:16:51","modified_gmt":"2021-10-01T14:16:51","slug":"astrazeneca-appeal-rejected-in-generics-favourable-decision-juve-patent","status":"publish","type":"presseberichte","link":"https:\/\/www.maiwald.eu\/en\/press-coverage\/astrazeneca-appeal-rejected-in-generics-favourable-decision-juve-patent\/","title":{"rendered":"AstraZeneca appeal rejected in generics-favourable decision (JUVE-Patent)"},"content":{"rendered":"\n

Second medical use is currently a hot topic in pharmaceutical patents. In the dispute over the breast cancer drug containing the active ingredient fulvestrant, the generics manufacturers have landed a further victory. D\u00fcsseldorf Higher Regional Court yesterday dismissed AstraZeneca’s appeal and an application for a preliminary injunction after only two hours of negotiations (case IDs: I-2 U 27\/18, I-2 U 28\/18, I-2 U 29\/18).<\/p>\n\n\n\n

Representatives:<\/strong><\/p>\n\n\n\n

For AstraZeneca
Hoffmann Eitle<\/strong> (Munich): Dirk Sch\u00fc\u00dfler-Langeheine, Michael Pfeifer, Thorsten Bausch, Ulrike Ciesla (both patent attorneys)
Novacos<\/strong> (D\u00fcsseldorf): Christian Stallberg
In-house<\/strong> (Macclesfield): Lucy Padget (senior patent director)<\/p>\n\n\n\n

For Hexal
Arnold Ruess<\/strong> (D\u00fcsseldorf): Cordula Schumacher, Marina Wehler, Lisa Schneider
df-mp D\u00f6rries Frank-Molnia & Pohlman<\/strong> (Munich): Elisabeth Greiner, Holger Schimmel (both patent attorneys)
Taylor Wessing<\/strong> (Munich): Manja Epping
In-house<\/strong> (Holzkirchen): Patricia Paias, Waltraud Fauss-Berghus<\/p>\n\n\n\n

For Ratiopharm
Bird & Bird<\/strong> (D\u00fcsseldorf): Oliver J\u00fcngst, Anna Wolters-H\u00f6hne, Annika Schneider,
Lederer & Keller<\/strong> (Munich): Michael Best (patent attorney)<\/p>\n\n\n\n

For Betapharm
Maiwald<\/strong> (Munich): Marco Stief<\/a>, Heike R\u00f6der-Hitschke<\/a>, Dirk B\u00fchler<\/a>, Renate Rieder<\/a> (both patent attorneys)
In-house<\/strong> (Cambridge): Mujeebur Rahiman (head IP Europe Dr. Reddy\u2019s)<\/p>\n\n\n\n

Higher Regional Court D\u00fcsseldorf, 2nd Civil Chamber
Thomas K\u00fchnen (presiding judge)<\/p>\n\n\n\n

The complete Juve-Patent article can be downloaded under:
https:\/\/www.juve-patent.com\/news-and-stories\/cases\/astrazeneca-appeal-rejected-in-generics-favourable-decision\/<\/a><\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-2087","presseberichte","type-presseberichte","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.maiwald.eu\/en\/wp-json\/wp\/v2\/presseberichte\/2087","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.maiwald.eu\/en\/wp-json\/wp\/v2\/presseberichte"}],"about":[{"href":"https:\/\/www.maiwald.eu\/en\/wp-json\/wp\/v2\/types\/presseberichte"}],"version-history":[{"count":1,"href":"https:\/\/www.maiwald.eu\/en\/wp-json\/wp\/v2\/presseberichte\/2087\/revisions"}],"predecessor-version":[{"id":9244,"href":"https:\/\/www.maiwald.eu\/en\/wp-json\/wp\/v2\/presseberichte\/2087\/revisions\/9244"}],"wp:attachment":[{"href":"https:\/\/www.maiwald.eu\/en\/wp-json\/wp\/v2\/media?parent=2087"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}